{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Administration+of+sitagliptin", "query": { "intervention": "Administration of sitagliptin" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 68, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Administration+of+sitagliptin&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T03:16:02.860Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06054815", "title": "Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "NON-ALCOHOLIC STEATOHEPATITIS" ], "interventions": [ { "name": "DA-1241", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" }, { "name": "DA-1241 Placebo", "type": "DRUG" }, { "name": "Sitagliptin Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeuroBo Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 109, "start_date": "2023-09-14", "completion_date": "2024-10-30", "has_results": false, "last_update_posted_date": "2024-11-14", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 18, "location_summary": "Coronado, California • Montclair, California • Panorama City, California + 12 more", "locations": [ { "city": "Coronado", "state": "California" }, { "city": "Montclair", "state": "California" }, { "city": "Panorama City", "state": "California" }, { "city": "Rialto", "state": "California" }, { "city": "Doral", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06054815" }, { "nct_id": "NCT02328040", "title": "Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "Placebo and Insulin monotherapy via CL", "type": "DRUG" }, { "name": "Sitagliptin and insulin/novolog via CL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albert Einstein College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "14 Years to 30 Years" }, "enrollment_count": 17, "start_date": "2014-09", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2018-08-07", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02328040" }, { "nct_id": "NCT00477581", "title": "A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "exenatide", "type": "DRUG" }, { "name": "sitagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 102, "start_date": "2007-05", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2015-08-26", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 19, "location_summary": "Los Angeles, California • Spring Valley, California • Miami, Florida + 15 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00477581" }, { "nct_id": "NCT00760344", "title": "Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "SYR-472", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 386, "start_date": "2007-03", "completion_date": "2008-03", "has_results": false, "last_update_posted_date": "2016-06-22", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 105, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 102 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00760344" }, { "nct_id": "NCT01794143", "title": "A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes", "Comparative Effectiveness of Glycemia-lowering Medications" ], "interventions": [ { "name": "Sulfonylurea (glimepiride)", "type": "DRUG" }, { "name": "DPP-4 inhibitor (sitagliptin)", "type": "DRUG" }, { "name": "GLP-1 receptor agonist (liraglutide)", "type": "DRUG" }, { "name": "Insulin (glargine)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GRADE Study Group", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 7850, "start_date": "2013-05", "completion_date": "2021-04-30", "has_results": true, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • San Diego, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01794143" }, { "nct_id": "NCT02639637", "title": "Effect of DPP4 Inhibition on Vasoconstriction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Neuropeptide Y", "type": "DRUG" }, { "name": "Enalaprilat", "type": "DRUG" }, { "name": "Valsartan 160mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 18, "start_date": "2015-12", "completion_date": "2017-09", "has_results": true, "last_update_posted_date": "2018-08-27", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02639637" }, { "nct_id": "NCT00838903", "title": "Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "albiglutide", "type": "BIOLOGICAL" }, { "name": "sitagliptin", "type": "DRUG" }, { "name": "glimepiride", "type": "DRUG" }, { "name": "metformin", "type": "DRUG" }, { "name": "placebo albiglutide", "type": "BIOLOGICAL" }, { "name": "placebo sitagliptin", "type": "DRUG" }, { "name": "placebo glimepiride", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1049, "start_date": "2009-02", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2017-01-09", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 317, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Hueytown, Alabama + 254 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00838903" }, { "nct_id": "NCT01845831", "title": "Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Basal Bolus", "type": "DRUG" }, { "name": "Metformin and Sitagliptin", "type": "DRUG" }, { "name": "Glargine", "type": "DRUG" }, { "name": "Glargine 50%", "type": "DRUG" }, { "name": "Glargine 80%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 292, "start_date": "2013-08", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 5, "location_summary": "Atlanta, Georgia • Ann Arbor, Michigan • Columbus, Ohio + 1 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01845831" }, { "nct_id": "NCT01378117", "title": "Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes Mellitus", "Hospitalization", "Hyperglycemia" ], "interventions": [ { "name": "Sitagliptin", "type": "DRUG" }, { "name": "glargine", "type": "DRUG" }, { "name": "lispro", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 90, "start_date": "2011-08", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2018-12-07", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01378117" }, { "nct_id": "NCT00466518", "title": "Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Kidney Transplant", "Type 2 Diabetes" ], "interventions": [ { "name": "Administration of sitagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 16, "start_date": "2007-04", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-09-04T03:16:02.860Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00466518" } ] }